Latest News

Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration

Knowles Expands RF Signal Chain Offering with New A-Series Attenuators

New Phase 3b data show Lilly's EBGLYSS (lebrikizumab-lbkz) delivered significant and rapid improvements in skin clearance, itch, pain, and patient satisfaction in people with moderate-to-severe hand and foot atopic dermatitis

Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards

Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Leapwork Play Reaches General Availability, Adding Enterprise Governance and Evidence to Playwright Test Automation

United States Antimony Corporation Provides Third Quarter Update on Antimony Shipments to the DoW

September Harvard Caps / Harris Poll: Democrats Hold A 2-Point Lead Among Likely Voters in Midterms Horserace, With Trump Approval Hitting a Low Of 42%

Black Book's 2027 ROI and HILM Report Names Verisma Leader as Healthcare Moves Beyond Records Release

Parabolic Announces $9.3 Million in Annualized Cost Savings from ConnectAndSell Integration and Business Unit Realignment